| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 5e-09 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |